Trial intelligence / Profile preview

TOF vs SOX in metastatic gastric cancer

NCT02442362Phase 3Completed

Sponsor
Changzhou First People's Hospital
Start
Jan 2012
Primary completion
Jan 2014
Modality
Small Molecules
01

Overview

Phase 3, randomised, open-label trial of tegafur in gastric cancer (GC), sponsored by Changzhou First People's Hospital. Started Jan 2012; status: completed.

02

Drugs

tegafur
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT02442362.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02442362.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call